Evidence map›Paper›PMID 32101987›Full record

ArticleBehavioural pharmacology2020

The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats.

William S Hyatt, Caitlin E Hirsh, Lauren N Russell, Neha M Chitre, Kevin S Murnane, Kenner C Rice, William E Fantegrossi

Open access · greenAbstract read
In one paragraph

Article in Behavioural pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

William S HyattDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Caitlin E HirshDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Lauren N RussellDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Neha M ChitreDepartment of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, Georgia.
Kevin S MurnaneDepartment of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, Georgia.
Kenner C RiceDrug Design and Synthesis Section, Intramural Research Program, National Institute of Drug Abuse, IRP, NIH, Baltimore, Maryland, USA.
William E FantegrossiDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
University of Arkansas for Medical Sciences · USMercer University Health Sciences Center · USNational Institute on Drug Abuse · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029884 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI LOWERY, CURTIS L · 2009 to 2011
$11.4M
Telemedicine CoreP30GM110702 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI GARCIA-RILL, EDGAR E. · 2014 to 2018
$6.1M
Translational Training in AddictionT32DA022981 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI Melissa Jean Zielinski · 2009 to 2026
$6.1M
Medicinal Chemistry of Drugs Acting on Biogenic Amine ReceptorsZIADA000532 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2020
$4.5M
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of AbuseR01DA039195 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI OWENS, SAMUEL MICHAEL · 2015 to 2018
$2.4M
Receptor pharmacology and toxicology of second-generation pyrrolidine "bath salt" cathinonesR21DA040907 · NIDA · NORTHEASTERN UNIVERSITY · PI CANAL, CLINTON E, MURNANE, KEVIN SEAN · 2016 to 2017
$493k
A novel neuropeptide brain delivery system for epilepsyR21NS100512 · NINDS · MERCER UNIVERSITY MACON · PI ESCAYG, ANDREW P, MURNANE, KEVIN SEAN · 2016 to 2017
$440k
NCRR NIH HHS UL1 RR029884NIDA NIH HHS R01 DA039195NIDA NIH HHS R21 DA040907NIDA NIH HHS T32 DA022981NIGMS NIH HHS P30 GM110702NINDS NIH HHS R21 NS100512
6 · The paper itself

Abstract

A previous study from our laboratory has shown that the selective catecholamine reuptake inhibitor 3,4-methylenedioxypyrovalerone (MDPV) persistently alters impulsive choice as measured by delay discounting. To further understand the proimpulsive effects of MDPV, we examined its capacity to modulate a different impulsive measure - impulsive action - using a differential reinforcement of low rates of responding task with an inter-response time of 20 s. Three groups of male, Sprague-Dawley rats (n = 6) were first tested in daily sessions to understand the acute effects of cocaine (1.0-30.0 mg/kg), MDPV (0.1-3.0 mg/kg), or saline (1.0 ml/kg) on impulsive action. Both cocaine and MDPV increased impulsive action, most notably by decreasing timing error responses and response efficiency, but MDPV was more effective than cocaine. Additionally, MDPV suppressed operant responding in two of six animals at the highest dose tested. Next, the same animals received 10 postsession injections, once every other day, of either 30.0 mg/kg cocaine, 3.0 mg/kg MDPV, or 1.0 ml/kg saline based on their treatment group. An acute dose-effect redetermination was completed following the repeated administration studies, and once again MDPV and cocaine demonstrated proimpulsive effects. Interestingly, timing error responses were decreased in both MDPV and cocaine groups after an acute saline injection, potentially indicating persistent impulsive changes following the repeated administration phase of the experiment. These studies indicate that MDPV increases impulsive action acutely and that this increase may be potentiated following a series of repeated administrations.

Indexed as

AnimalsBenzodioxolesCocaineConditioning, OperantDose-Response Relationship, DrugImpulsive BehaviorMalePyrrolidinesRatsReinforcement ScheduleSynthetic CathinoneBenzodioxolesCocainePyrrolidinesSynthetic Cathinone

Identifiers

PMID32101987
PMCPMC9356379
OpenAlexW3008491663

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.